š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This randomized, open-label, active-controlled trial will assess humoral im...
Status
Completed
Location
Soroka Medical Center
Start Date
2019-10-31
Trial ID
NCT04523324
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of a...
Status
Completed
Location
Joint Clinical Trials Huntington Park Site Number : 8400032
Start Date
2022-11-28
Trial ID
NCT05624606
The purpose of this study is to evaluate the safety and immunogenicity of a...
Status
Completed
Location
Peninsula Research Associates Site Number : 8400025
Start Date
2022-10-03
Trial ID
NCT05553301
This is a Phase 1, parallel, randomized, active-controlled, multi-center, d...
Status
Completed
Location
Investigational Site Number : 0360004
Start Date
2023-04-12
Trial ID
NCT05829356
Treatments Being Tested
This randomized, open-label trial will assess humoral and cell-mediated imm...
Status
Completed
Location
Kaiser Permanente Northwest
Start Date
2018-09-12
Trial ID
NCT03722589
Treatments Being Tested
The purpose of this study was to evaluate the safety and immunogenicity of ...
Status
Completed
Location
California Research Foundation Site Number : 8400038
Start Date
2024-04-01
Trial ID
NCT06361875
The aims of this vaccine trial are: (1) to measure humoral and selected cel...
Status
Completed
Location
The University of Hong Kong
Start Date
2020-10-05
Trial ID
NCT04576377
The purpose of this study is to evaluate the safety and immunogenicity of a...
Status
Completed
Location
Velocity Clinical Research-Chula Vista Site Number : 8400061
Start Date
2022-12-12
Trial ID
NCT05650554
Randomized, double-blind trial of safety and immunogenicity of Flublok Quad...
Status
Completed
Location
Benchmark Research - Sacramento
Start Date
2014-10
Trial ID
NCT02290509
Treatments Being Tested
The primary objectives of this study were: * To describe the immunogenicit...
Status
Completed
Location
Investigational Site Number 8400003
Start Date
2018-09-10
Trial ID
NCT03617523